🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06527274
Active, not recruiting Not applicable

Effect of Defocus in Soft Contact Lenses on Internal Retinal Vascularization

NCT06527274 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-06-25
Last updated
2025-03-27

Condition(s) studied

Nearsightedness

Investigational drug(s) / intervention(s)

Experimental: Myopic defocus soft lens design (MDSL)Active Comparator: Single vision soft lens design (SVSL

Experimental: Myopic defocus soft lens design (MDSL): An optical device designed to provide a myopic defocus to control myopia progression

Active Comparator: Single vision soft lens design (SVSL: An optical device designed to correct refractive error like myopia

Study summary

The purpose of this study is to gain a better understanding of the retinal vascular changes that occur in response to the optical effect of a myopic defocus daily disposable soft contact lens (MDSL) in a group of healthy young myopic adults (18-35 years; myopia -1.00D to -4.00D; all genders). It will also learn about the acceptance of this visual correction modality compared to regular contact lenses.

The main questions to be answered are:

* To evaluate changes in retinal blood flow by visualizing retinal vascular density in the superficial and deep plexus after one week of MDSL wear.
* To evaluate changes in choroidal thickness at the macular level after one week of MDSL wear.
* To evaluate the visual comfort provided by this MDSL design using a questionnaire.

Researchers will compare the MDSL to a daily disposable single vision soft lens (SVSL) used to correct myopia to determine if the addition of a defocus area makes a difference in the retinal response to the visual signal.

Participants will be required to

* Wear both MDSL and SVSL for one week each, in a random order.
* Read letters to measure visual acuity
* Have a deep scan of their retina with an optical coherence tomography (OCT) device
* Rate the comfort and vision provided by both devices using a questionnaire.

Eligibility

Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * · Astigmatism ≤ 1.00 D * Myopia between -0.50 and -4.00D * Aged between 18 and 35 * Binocular acuity of 6/6 or better Exclusion Criteria: * · Recent intake (\< 3 months) of medication affecting blood pressure (e.g. hypotensive, anovulant, CNS stimulant, etc.). * Corneal dystrophy or irregularity * Use of topical ocular medications * Smoking (tobacco or marijuana) * Have contraindications to wearing soft contact lenses * Being currently under myopia control treatment or had been under control in the last 3 months * Being pregnant or breast-feeding * History of refractive surgery * Addiction to drugs or alcohol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universite de Montreal Montreal Quebec

More Université de Montréal trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06527274 on ClinicalTrials.gov ↗ ← All trials in Canada